Are heart failure patients with mildly reduced ejection fraction treated according to current international guidelines?

Back

ESC Professional Premium Access

Are heart failure patients with mildly reduced ejection fraction treated according to current international guidelines?

Session: Improving outcomes in heart failure: bench to bedside

Topic: Beta-Blockers

Speaker: Doctor T. Schupp (Mannheim, DE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Tobias Schupp

University Medical Centre of Mannheim, Mannheim (Germany)

0 follower

8 more presentations in this session

The power of optimal medical therapy in heart failure with secondary mitral regurgitation

Speaker: Unknown A. Borrellas Martin (Barcelona, ES)

Prescribing trends of sodium-glucose cotransporter 2 Inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction

Speaker: Doctor F. Hofer (Vienna, AT)

Successful treatment of pulmonary hypertension and right heart failure by antibody-based functional blocking of the extra-domain A of fibronectin in a preclinical animal model

Speaker: Professor M. Franz (Rotenburg an der Fulda, DE)

Effects of colchicine treatment after myocardial infarction on top of standard therapy: evidence from a preclinical study

Speaker: Doctor A. Aimo (Pisa, IT)

Acute over-additive natriuretic effects by a combination of finerenone and SGLT2 inhibition in rats with an activated renin-angiotensin-aldosterone system: a mechanistic basis for clinical outcomes?

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Access the full session

Improving outcomes in heart failure: bench to bedside

Speakers: Doctor T. Schupp, Unknown A. Borrellas Martin, Doctor F. Hofer, Professor M. Franz, Doctor A. Aimo...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Are heart failure patients with mildly reduced ejection fraction treated according to current international guidelines?

About the speaker

Doctor Tobias Schupp

8 more presentations in this session

The power of optimal medical therapy in heart failure with secondary mitral regurgitation

Prescribing trends of sodium-glucose cotransporter 2 Inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction

Successful treatment of pulmonary hypertension and right heart failure by antibody-based functional blocking of the extra-domain A of fibronectin in a preclinical animal model

Effects of colchicine treatment after myocardial infarction on top of standard therapy: evidence from a preclinical study

Acute over-additive natriuretic effects by a combination of finerenone and SGLT2 inhibition in rats with an activated renin-angiotensin-aldosterone system: a mechanistic basis for clinical outcomes?

Access the full session

Improving outcomes in heart failure: bench to bedside

About the event

ESC Congress 2023

ESC 365 is supported by